Apelin: A potential marker of coronary artery stenosis and atherosclerotic plaque stability in ACS patients

International Heart Journal

Volumn 55, Issue 3, 2014, Pages 204-212

  Zhou, Ying ^a   Wang, Yong ^b   Qiao, Shubin ^a  

^a FUWAI HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Acute coronary syndrome; Intravascular ultrasound

Indexed keywords

APELIN; BRAIN NATRIURETIC PEPTIDE; CREATININE; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; GLYCERYL TRINITRATE;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL DIAMETER; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; DISEASE SEVERITY; ENZYME IMMUNOASSAY; EXTERNAL ELASTIC MEMBRANE; FEMALE; GENSINI SCORE; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR GUIDE WIRE; VASCULARIZATION;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84901479618     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.13-234     Document Type: Article

References (38)

1. Falcão-Pires I, Leite-Moreira AF. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 2005; 24: 1263-76. (Review) (Portuguese)
2. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and charcaterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-6
3. Katugampola S, Davenport A. Emerging roles for orphan G-protein- coupled receptors in the cardiovascular system. Trends Pharmacol Sci 2003; 24: 30-5. (Review)
4. Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 2005; 126: 233-40
5. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004; 118: 119-25
6. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005; 107: 198-211. (Review)
7. Zhong JC, Yu XY, Huang Y, Yung LM, Lau CW, Lin SG. Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 2007; 174: 388-95
8. Hashimoto T, Kihara M, Ishida J, et al. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2006; 26: 1267-72
9. Farkasfalvi K, Stagg MA, Coppen SR, et al. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 2007; 357: 889-95
10. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 2006; 553: 222-8
11. Szokodi I, Tavi P, Földes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002; 91: 434-40
12. Japp AG, Cruden NL, Amer DA, et al. Vascular effects of apelin in vivo in man. J Am Coll Cardiol 2008; 52: 908-13
13. Hashimoto T, Kihara M, Imai N, et al. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol 2007; 171: 1705-12
14. Chun HJ, Ali ZA, Kojima Y, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008; 118: 3343-54
15. Kuklinska AM, Sobkowicz B, Sawicki R, et al. Apelin: a novel marker for the patients with fi rst ST-elevation myocardial infarction. Heart Vessels 2010; 25: 363-7
16. Li Z, Bai Y, Hu J. Reduced apelin levels in stable angina. Inter Med 2008; 47: 1951-5
17. Weir RA, Chong KS, Dalzell JR, et al. Plasma apelin concentration is depressed following acute myocardial infarction in man. Eur J Heart Fail 2009; 11: 551-8
18. Pitkin SL, Maguire JJ, Kuc RE, Davenport AP. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol 2010; 160: 1785-95
19. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to refl ect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990; 119: 1262-7
20. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606
21. Kusama I, Hibi K, Kosuge M, et al. Intravascular ultrasound assessment of the association between spatial orientation of ruptured coronary plaques and remodeling morphology of culprit plaques in ST-elevation acute myocardial infarction. Heart Vessels 2012; 27: 541-7
22. Gualillo O, González-Juanatey JR, Lago F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med 2007; 17: 275-83. (Review)
23. Losano G, Penna C, Cappello S, Pagliaro P. Activity of apelin and APJ receptors on myocardial contractility and vasomotor tone. Ital Heart J Suppl 2005; 6: 272-8. (Review) (Italian)
24. Katugampola SD, Kuc RE, Maguire JJ, Davenport AP. G-proteincoupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors. Clin Sci (Lond) 2002; 103 Suppl 48: 171S-5S.
25. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 1983; 71: 1854-66
26. Földes G, Horkay F, Szokodi I, et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003; 308: 480-5
27. Liao YC, Chou WW, Li YN, et al. Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women. Am J Clin Nutr 2011; 94: 921-8
28. Berry MF, Pirolli TJ, Jayasankar V, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004; 110: II187-93
29. Ashley EA, Powers J, Chen M, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005; 65: 73-82
30. Chong KS, Gardner RS, Morton JJ, Ashley EA, McDonagh TA. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail 2006; 8: 355-60
31. Francia P, Salvati A, Balla C, et al. Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin. Eur J Heart Fail 2007; 9: 306-9
32. Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003; 108: 1432-9
33. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-72
34. van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 2009; 135: 60-5
35. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 1990; 82: II47-59. (Review)
36. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127-34
37. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565-9
38. Uzui H, Sinha SK, Rajavashisth TB. 17β-estradiol inhibits oxidized low-density lipoprotein-induced increase in matrix metalloproteinase- 9 expression in human macrophages. J Investig Med 2011; 59: 1104-8.